方法：对研究期间住院94例102眼青光眼患者予Ahmed青光眼阀门植入术，新生血管性青光眼患者术后1～2wk予全视网膜光凝。术后随访6mo以上，了解各期眼压、视力情况。

结果：平均眼压从术前48.52±6.42mmHg降到术后6mo 11.20±3.34mmHg。术后各时期平均眼压均低于21mmHg，与术前相比差异有显著性(P<0.01)。102眼手术完全成功者96眼，基本成功者2眼，总有效率为96.1%。术后并发症包括短暂性前房出血、早期低眼压、浅前房等。

结论：尽管Ahmed阀门植入存在一些并发症，但是对于青光眼是一种新的有效治疗方法。

METHODS: Totally 94 cases 102 glaucoma eyes underwent Ahmed valve implantation.Neovascular glaucoma eyes were treated with retinal photocoagulation 1-2 weeks after operation. Patients were followed up for over a six-month period.

RESULTS: The mean intraocular pressure(IOP)was lowered from 48.52±6.42mmHg preoperatively to 11.20±3.34mmHg postoperatively. Compared with preoperative IOP, the IOP at each period after surgery was significantly lower(P<0.01). Complete success was achieved in 96 eyes and there was qualified success in 2 eyes. The total success rate was 96.1%. Some of the complications were transient hyphema, early post-operative hypotony, and a transient shallow anterior chamber.

CONCLUSION: AGV implantation is a new and effective technique in glaucoma.